CATION EXCHANGE URETERAL STENT
    43.
    发明申请
    CATION EXCHANGE URETERAL STENT 有权
    切口交替性尿失禁

    公开(公告)号:US20140188248A1

    公开(公告)日:2014-07-03

    申请号:US14136969

    申请日:2013-12-20

    Inventor: Neena GANDHI

    Abstract: An endoluminal prosthesis for placing in a body passage of a patient, includes a ureteral stent, the ureteral stent having a generally tubular housing having a proximal end and a distal end and a lumen longitudinally disposed therethrough, with cation-exchange resin beads disposed within the tubular housing, and at least one anchoring mechanism disposed on a distal end of the tubular housing, where at least one retention screen is disposed within the lumen of the ureteral stent configured to retain the plurality of beads.

    Abstract translation: 用于放置在患者的身体通道中的腔内假体包括输尿管支架,输尿管支架具有大致管状的壳体,其具有近端和远端以及纵向设置在其中的内腔,阳离子交换树脂珠置于内 管状壳体,以及设置在管状壳体的远端上的至少一个锚固机构,其中至少一个保持屏布置在输尿管支架的内腔内,其配置为保持多个珠。

    WATER TREATMENT
    44.
    发明申请
    WATER TREATMENT 有权
    水处理

    公开(公告)号:US20140186242A1

    公开(公告)日:2014-07-03

    申请号:US13876445

    申请日:2011-09-28

    Abstract: The invention provides a method of reducing the sodium content of a water containing dissolved sodium ions, particularly a water with a sodium ion content of at least 100 ppm. Examples of such waters are effluents such as acid mine drainage and river waters. The method includes the steps of: (i) removing sodium, calcium and magnesium ions from the water by contacting the water with a cation exchange resin/s to capture sodium, calcium and magnesium ions thereon, (ii) treating the cation exchange resin/s of step (i) with nitric acid to produce an eluant containing sodium ions, calcium ions, magnesium ions nitrate ions and nitric acid, (iii) adding a carbonate to the eluant to precipitate the calcium and magnesium ions as calcium and magnesium carbonates; (iv) separating the precipitated carbonates from the eluant; and (v) treating the eluant from step (iv) to obtain a sodium and/or potassium nitrate product.

    Abstract translation: 本发明提供一种降低含有溶解的钠离子,特别是钠离子含量至少为100ppm的水的钠的钠含量的方法。 这种水域的例子是排水,如酸性矿井排水和河水。 该方法包括以下步骤:(i)通过使水与阳离子交换树脂接触来从水中除去钠,钙和镁离子,以在其上捕获钠,钙和镁离子,(ii)将阳离子交换树脂/ 步骤(i)用硝酸生成含有钠离子,钙离子,镁离子硝酸根离子和硝酸的洗脱剂,(iii)向洗脱剂中加入碳酸盐以使钙和镁离子作为碳酸钙和镁酸盐沉淀; (iv)将沉淀的碳酸盐与洗脱液分离; 和(v)处理来自步骤(iv)的洗脱液以获得硝酸钠和/或硝酸钾产物。

    Water softener regeneration
    45.
    发明授权
    Water softener regeneration 有权
    水软化剂再生

    公开(公告)号:US08663476B2

    公开(公告)日:2014-03-04

    申请号:US12365856

    申请日:2009-02-04

    Applicant: Francis Boodoo

    Inventor: Francis Boodoo

    Abstract: A new process for ion exchange softening of water used in Once-Through Steam Generators (OTSGs) by recovering and using the salt content of the blowdown water from the OTSG to regenerate the softener resin is provided, thus eliminating the cost for commercial regenerant salt that would otherwise be needed. Further, the very high purity of the salt recovered in the blowdown inherently results in the production of softened water with hardness leakage levels that are an order of magnitude lower than can be attained using commercial salt, thus reducing scale deposit potential and improving operating efficiency and reliability of the OTSG.

    Abstract translation: 提供了一种通过回收和使用来自OTSG的排污水的盐含量来再生软化剂树脂的用于一次通过蒸汽发生器(OTSG)中的水的离子交换软化的新方法,从而消除了商业再生盐的成本, 否则将需要。 此外,在排污中回收的盐的非常高的纯度固有地导致软化水的生产,其硬度泄漏水平比使用商业盐可以获得的量级低一个数量级,从而降低沉积潜力并提高操作效率, OTSG的可靠性。

    Composition and Method for Arresting Blood Flow and for Forming a Persistent Microbial Barrier
    50.
    发明申请
    Composition and Method for Arresting Blood Flow and for Forming a Persistent Microbial Barrier 审中-公开
    阻止血液流动和形成持久性微生物屏障的组成和方法

    公开(公告)号:US20120087887A1

    公开(公告)日:2012-04-12

    申请号:US12900170

    申请日:2010-10-07

    CPC classification number: A61K31/795 B01J39/05 B01J39/20

    Abstract: A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when applied over blood, provides an antimicrobial against planktonic microorganisms and biofilms in the wound. The resin is also capable, when applied in sufficient quantities, of providing a continuing and persistent antimicrobial against planktonic microorganisms and biofilms through dehydration and ion exchange with cations present in the blood and other body fluids. When the resin has a concentration of at least 26 mg/ml, it provides a >3 log reduction in biological activity of MRSA, MRSE and Pseudomonas aeruginosa.

    Abstract translation: 用于促进出血性伤口部位愈合的组合物和方法。 该组合物优选包括基本上无水的阳离子交换树脂形式,其当在血液上施用时,提供对伤口中的浮游微生物和生物膜的抗微生物剂。 当应用足够量时,树脂还能够通过与存在于​​血液和其它体液中的阳离子进行脱水和离子交换来提供对浮游微生物和生物膜的持续和持续的抗微生物。 当树脂的浓度至少为26mg / ml时,提供MRSA,MRSE和绿脓假单胞菌生物活性降低> 3log。

Patent Agency Ranking